NIH Advisory Meeting Dates Shifted
Published Date: 5/19/2026
Notice
Summary
The National Center for Advancing Translational Sciences changed its big advisory meeting dates. The main meeting now runs May 21-22, 2026, with a new open session added on May 21 and a closed session moved to July 16 due to some delays. This affects anyone following the center’s plans and means more time to review important reports before decisions are made.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)
The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
Previous / Next Documents
Previous: 2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Next: 2026-09949 — Global Laser Enrichment, LLC; Establishment of Atomic Safety and Licensing Board
Global Laser Enrichment, LLC wants to build and run a new uranium enrichment plant in Kentucky using cool laser technology. To make sure everything’s safe and follows the rules, a special board of judges has been set up to review and hold a hearing once safety and environmental checks are done. This process affects the company, local community, and regulators, with important decisions coming soon that could impact the project’s timeline and costs.